New therapeutic perspectives on protein-bound uremic toxins in chronic kidney disease

被引：5
|
作者：
Malyszko, Jolanta [1 ,2 ]
机构：
[1] Med Univ, Dept Nephrol 2, PL-15276 Bialystok, Poland
[2] Hypertens Dialysis Unit, PL-15276 Bialystok, Poland
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2014年 / 18卷 / 02期
关键词：
AST-120; chronic kidney disease; indoxyl sulfate; uremic toxins; CHRONIC-RENAL-FAILURE; P-CRESOL SULFATE; INDOXYL SULFATE; DIALYZER MEMBRANE; ORAL ADSORBENT; REMOVAL; AST-120; HEMODIALYSIS; PROGRESSION; SOLUTES;
D O I：
10.1517/14728222.2014.860966
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The uremic syndrome is a complex mosaic of clinical alterations that may be attributable to one or more of these different solutes. Uremic symptoms in patients with chronic kidney disease are primarily a consequence of inadequate removal and subsequent accumulation of organic products normally metabolized or excreted by the kidney.
引用
收藏
页码：109 / 113
页数：5
相关论文
共 50 条
  • [21] AST-120 to target protein-bound uremic toxins improves cardiac output and kidney oxygenation in experimental chronic kidney disease.
    Sivertsson, Ebba
    Ceder, Sara
    Nangaku, Masaomi
    Hansell, Peter
    Nordquist, Lina
    Palm, Fredrik
    KIDNEY & BLOOD PRESSURE RESEARCH, 2023, 48 (01): : 114 - 123
  • [22] DIET QUALITY, PROTEIN-BOUND URAEMIC TOXINS AND GASTROINTESTINAL MICROBIOME IN CHRONIC KIDNEY DISEASE
    McFarlane, Catherine
    Krishnasamy, Rathika
    Stanton, Tony
    Savill, Emma
    Snelson, Matthew
    Mihala, Gabor
    Morrison, Mark
    Johnson, David W.
    Campbell, Katrina L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [23] Disposition and clinical implications of protein-bound uremic toxins
    Jansen, Jitske
    Jankowski, Joachim
    Gajjala, Prathibha R.
    Wetzels, Jack F. M.
    Masereeuw, Rosalinde
    CLINICAL SCIENCE, 2017, 131 (14) : 1631 - 1647
  • [24] The Therapeutic Strategies for Uremic Toxins Control in Chronic Kidney Disease
    Lu, Ping-Hsun
    Yu, Min-Chien
    Wei, Meng-Jiun
    Kuo, Ko-Lin
    TOXINS, 2021, 13 (08)
  • [25] Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease
    Sanchez-Ospina, Didier
    Mas-Fontao, Sebastian
    Gracia-Iguacel, Carolina
    Avello, Alejandro
    de Rivera, Marina Gonzalez
    Mujika-Marticorena, Maddalen
    Gonzalez-Parra, Emilio
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [26] Update on the Pharmacokinetics and Redox Properties of Protein-Bound Uremic Toxins
    Watanabe, Hiroshi
    Miyamoto, Yohei
    Otagiri, Masaki
    Maruyama, Toru
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (09) : 3682 - 3695
  • [27] Cardiorenal Syndrome The Emerging Role of Protein-Bound Uremic Toxins
    Lekawanvijit, Suree
    Kompa, Andrew R.
    Wang, Bing H.
    Kelly, Darren J.
    Krum, Henry
    CIRCULATION RESEARCH, 2012, 111 (11) : 1470 - 1483
  • [28] COMPARISON OF EXTRACORPOREAL THERAPIES FOR PROTEIN-BOUND UREMIC TOXINS REMOVAL
    Maheshwari, Vaibhav
    Thijssen, Stephan
    Tao, Xia
    Fuertinger, Doris
    Kappel, Franz
    Kotanko, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [29] Protein-bound uremic toxins impaired mitochondrial dynamics and functions
    Sun, Chiao-Yin
    Cheng, Mei-Ling
    Pan, Heng-Chih
    Lee, Jia-Hung
    Lee, Chin-Chan
    ONCOTARGET, 2017, 8 (44) : 77722 - 77733
  • [30] Clearance of Protein-Bound Uremic Toxins on the Tablo Hemodialysis System
    Rivas, Logan
    Hu, Dean
    Aragon, Michael A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 315 - 316
12345